Literature DB >> 8391735

Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

T Terada1, K Ueda, Y Nakanuma.   

Abstract

Atypical adenomatous hyperplasia (AAH) is a hyperplastic parenchymal nodular change in the cirrhotic liver, in which overt hepatocellular carcinoma (HCC) occasionally arises. AAH is defined as a sizable hepatocellular nodule with a variable degree of hepatocellular atypia not regarded as HCC, and is different from ordinary adenomatous hyperplasia in which hepatocellular atypia is absent. In the present study, we attempted to evaluate carcinogenetic processes and to find histological variables which indicate malignant transformation in AAH, using 49 surgically resected or autopsied nodules. AAH frequently showed morphological heterogeneity. Atypical lesions within AAHs were divisible into the following three categories from overall histopathological appearances: malignant (A), equivocal (B), or non-malignant (C) lesions. Analysis of combination of these three lesions, which were frequently intermixed in a given AAH, suggested that B lesions appear subsequent to C lesions, and A lesions finally appear in AAH nodules. Among the 14 histological variables, enlargement, hyperchromasia and irregular contour of nuclei were found to correlate well with A lesions. Increased nuclear density, iron resistance, reduction of reticulin fibres, clear cell change, sinusoidal dilatation and presence of abnormal arteries were suggestive of A or B lesions. Nuclear deviation toward the sinusoids, acinar and compact arrangements, fatty change and Mallory's hyaline alone were not useful indicators of A or B lesions. These results indicate that AAH is a preneoplastic or borderline lesion in which overt HCC is likely to evolve through several steps. Although a needle liver biopsy is a useful tool for diagnosis of benign, equivocal and malignant hepatocellular nodular lesions, the needle biopsy specimen should be carefully evaluated by considering the morphological heterogeneity of the AAH and a variable combination of 14 histological variables.

Entities:  

Mesh:

Year:  1993        PMID: 8391735     DOI: 10.1007/bf01605457

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  26 in total

1.  Morphological precursors of hepatocellular carcinoma: a morphometrical analysis.

Authors:  A Giannini; G Zampi; F Bartoloni; S Omer
Journal:  Hepatogastroenterology       Date:  1987-06

2.  Morphological clues for the diagnosis of small hepatocellular carcinomas.

Authors:  F Kondo; N Hirooka; K Wada; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; M Terada; H Hasegawa
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

4.  Morphometric analysis of hepatocellular carcinoma.

Authors:  F Kondo; K Wada; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

5.  Small liver masses in cirrhotic patients. A pathological clue for the morphogenesis of human hepatocellular carcinoma.

Authors:  W F Grigioni; A D'Errico; F Bacci; R Carella; A M Mancini
Journal:  Acta Pathol Jpn       Date:  1989-08

6.  Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.

Authors:  T Terada; Y Nakanuma
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

7.  Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers.

Authors:  L Ferrell; T Wright; J Lake; J Roberts; N Ascher
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

8.  Histological and morphometrical indicators for a biopsy diagnosis of well-differentiated hepatocellular carcinoma.

Authors:  Y Nagato; F Kondo; Y Kondo; M Ebara; M Ohto
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

9.  Expression of ABH blood group antigens, receptors of Ulex europaeus agglutinin I, and factor VIII-related antigen on sinusoidal endothelial cells in adenomatous hyperplasia in human cirrhotic livers.

Authors:  T Terada; Y Nakanuma
Journal:  Hum Pathol       Date:  1991-05       Impact factor: 3.466

10.  Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions.

Authors:  I Motohashi; M Okudaira; T Takai; S Kaneko; N Ikeda
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

View more
  8 in total

1.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

2.  Hepatocellular carcinoma and the underlying mechanisms.

Authors:  A A Oyagbemi; O I Azeez; A B Saba
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

3.  Extracellular matrix proteins, integrin receptors (VLA-beta 1, VLA-alpha 2 and VLA-alpha 5) and growth fraction in atypical macroregenerative nodules of the liver: an immunocytochemical case study.

Authors:  C Patriarca; M Roncalli; G Viale; R M Alfano; P Braidotti; F Guddo; G Coggi
Journal:  Histochemistry       Date:  1994-08

4.  Recent insights on risk factors of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid
Journal:  World J Hepatol       Date:  2009-10-31

5.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Authors:  Matthew M Yeh; Hubert Darius-J Daniel; Michael Torbenson
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

6.  Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.

Authors:  T Terada; Y Nakanuma
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  A case of small well-differentiated hepatocellular carcinoma with marked lymphocytic infiltrate.

Authors:  Tomohiro Iwasaki; Aki Kubota; Makoto Suzuki; Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

8.  Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma.

Authors:  Aileen Wee
Journal:  Cytojournal       Date:  2005-06-08       Impact factor: 2.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.